Primary Record
NS-220
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,924 g
- Purity
- 98.7 %
- CAS
- 377731-45-8
Compound Identifiers & Properties
- CAS
- 377731-45-8
- PubChem CID
- 9947731
- SMILES
- CC1=CC=C(C=C1)C2=NC(=C(O2)C)CCCCC3COC(OC3)(C)C(=O)O
- Canonical SMILES
- Cc1ccc(-c2nc(CCCCC3COC(C)(C(=O)O)OC3)c(C)o2)cc1
Names & Synonyms
- NS-220
- D08LZI
- D0C0ZC
- CHEMBL270960
- GTPL2678
- orb1699812
- SCHEMBL1771340
- SCHEMBL5856065
- SCHEMBL30866414
- AZ-628
- BDBM50225835
- AKOS040749042
- CID9947731
- LS-191458
- HY-19425
- Mutant B-Raf Kinase inhibitors, AstraZeneca
- J1.844.118G
- R-1593
- 377731-45-8
- Q27088055
- 2-methyl-5-[4-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]butyl]-1,3-dioxane-2-carboxylic Acid
- Mutant B-Raf (V600E) kinase inhibitors (cancer), AstraZeneca
- cis-2-methyl-5-(4-(5-methyl-2-p-tolyloxazol-4-yl)butyl)-1,3-dioxane-2-carboxylic acid
- (2s,5s)-2-methyl-5-(4-(5-methyl-2-(p-tolyl)oxazol-4-yl)butyl)-1,3-dioxane-2-carboxylic acid
- (2s,5s)-2-methyl-5-(4-(5-methyl-2-p-tolyloxazol-4-yl)butyl)-1,3-dioxane-2-carboxylic acid
- (2s,5s)-2-methyl-5-{4-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]butyl}-1,3-dioxane-2-carboxylic acid
- 2-Methyl-5alpha-[4-(2-toluene-4-yl-5-methyloxazole-4-yl)butyl]-1,3-dioxane-2alpha-carboxylic acid
- 2-methyl-c-5-{4-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]butyl}-1,3-dioxane-r-2-carboxylicacid
- Cis-2-Methyl-5-[4-[5-methyl-2-(4-methylphenyl)oxazol-4-yl]butyl]-1,3-dioxane-2-carboxylic acid